Autolus Therapeutics Reports Financial and Operational Results for the Transition Period from October 1 to December 31, 2018

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. FDX
3. META
4. ABBV
5. SPY
6. ACN
7. IBM
8. NKE
9. MU
10. AWK

Go back to Autolus Therapeutics Reports Financial and Operational Results for the Transition Period from October 1 to December 31, 2018

Autolus Therapeutics (AUTL) Reports Q4 Loss of $0.52

February 25, 2019 6:01 AM EST

Autolus Therapeutics (NASDAQ: AUTL) reported Q4 EPS of ($0.52), versus ($1.42) reported last year.

"In 2019, we expect significant progress that will build on the momentum of last year," stated Dr. Christian Itin, chairman and chief executive officer of Autolus. "Our robust pipeline of clinical and... More